{"name":"ICOS Corporation","slug":"icos-corporation","ticker":"","exchange":"","domain":"","description":"Icos Corporation was an American biotechnology company and the largest biotechnology company in the U.S. state of Washington, before it was sold to Eli Lilly and Company in 2007. It was founded in 1989 by David Blech, Isaac Blech, Robert Nowinski, and George Rathmann, a pioneer in the industry and chief executive officer (CEO) and co-founder of Amgen. Icos focused on the development of drugs to treat inflammatory disorders. During its 17-year history, the company conducted clinical trials of twelve drugs, three of which reached the last phase of clinical trials. Icos also manufactured antibodies for other biotechnology companies.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNM01QUnB1TWdIX0hIUDY3N01hMnctU0FOQVpNLTcyWGpYMV9Ic0Y5TE51eEo4a1BEM2RJODBkUkRSQ014T0xsZjRPMkFBU2plSXprbUdXSEVOSGNNN1hBUXA4cktFd182cjVFaUNFZTNnQmg1UG1UQmNNU1Jic0hMRmVZVkpSZHZNaHFzSVlfMmwwdV9tbTlpYzlSckUxbThtd2tzUENPVmh6a0FaY09EaXhsS3BWTU9CNVRDZ3hUWlY5eFJSX28w?oc=5","date":"2023-08-14","type":"pipeline","source":"GeekWire","summary":"Seattle company founded by Nobel Prize winner plans human tests for experimental COVID-19 drug - GeekWire","headline":"Seattle company founded by Nobel Prize winner plans human tests for experimental COVID-19 drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPQ1Q2V2QxSHdoN21sbm1rNEVKRE9rYllCRHF4VDBCN21Fc2Q4dldsaGVsXzA4NmFaeVdsbVpldEZ5SVd2SEhIZFZZczVwRmVOR1U0T0xBbzlLUllNWFBXcEd1Y2tvUDZYYTVVM2IzQ1ZxbnV0VzZPbUJDelNudnI5aXdPc28?oc=5","date":"2022-10-04","type":"patent","source":"JD Supra","summary":"Canada’s new patent claim fee rules: Alternative embodiments within a single claim - JD Supra","headline":"Canada’s new patent claim fee rules: Alternative embodiments within a single claim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxONlEzQmhPaUxtSnhZQm00cEZnWm1iUmNvaHVPdVlROHBsY1BkRHZRMHMwZVA1YWVOUkRXck5LZS1NdnEyR2l1NU9BdEJ1akhpaXZQZDUwQ0lQZHhLYk1JdFd4SEVnMGpqVi1yYTVfRmU2THVsOF93MU1sS0dERi0xeHRKTTlVeXpVdV9oLUdxR3lDYnc?oc=5","date":"2022-08-31","type":"pipeline","source":"pharmaphorum","summary":"Jounce setback casts deeper pall over ICOS as cancer target - pharmaphorum","headline":"Jounce setback casts deeper pall over ICOS as cancer target","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQeklpWU5TZHU1ZWw2UUdnT1JSMF9vUzI5ajJIWkMzaWV4LVhaMTlkdUFhZGRWU3RQZXVHN0k3TGN0QV9YbHJkYVNvbERqNmc3U0JQbjAwVjRwQWFXYUh5MDRKQmZROWQwcEpfbHg4VGI0UTB6QXZGNmU4YVRYb1B0MVFaMV9tbFBNVlp6YWxmc0cyMjdQRTBoZA?oc=5","date":"2022-03-27","type":"regulatory","source":"Dermatology Times","summary":"Optimize Off-Label Use of Biologics and New Medications - Dermatology Times","headline":"Optimize Off-Label Use of Biologics and New Medications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNX3FrekxVNWREajlZREhCNm0tRU9LVDRBMHBrRHJUdWVTRjJkam5OM2hsbUFORHZoM1FuNjVXdnJtRzB1cER1Y21WNE5tdFR6b3ZCd2s0ODFPQldfXzFJWmt6VjBXRVR2eUNGYUhENXpCcVRxQ3ItU0pQYnVFcHQzc3VqTGhOajREcmUtY2ZjRQ?oc=5","date":"2021-10-07","type":"pipeline","source":"Legacy","summary":"Merl Hoekstra Obituary (1959 - 2016) - Monroe, WA - The Herald (Everett) - Legacy","headline":"Merl Hoekstra Obituary (1959 - 2016) - Monroe, WA - The Herald (Everett)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQWUtKYVdLNzBHTFUxMzB6TUpjdE1VNHNmOVdZSEpESzM2QVRfel91RVJTTE11YnJoZFRQR2pyQy1hYWdUSm9EVVItdkVtZmFyWHZJN2VTamt5cmxLQzN4NVcyeHFTa2dtLWI2NDR5Y29BdTN1XzRoRHVwbUFER3UtcGpqQjdOTmVXSEQ4NEg2alo5NmFJVVlfMjFFTmFOY1drN2RHeWdGQnRlR2Jpa2JnR0JmQUF2eUFnZ0plRkdCTXg?oc=5","date":"2019-07-28","type":"patent","source":"Jones Day","summary":"France Rules on Patent Revocation Interest to Sue - Jones Day","headline":"France Rules on Patent Revocation Interest to Sue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPWHNYbXdKb2k3d0VTSlFGYm9MSWpWdW9hakxMc3JDam5MdGtXb2Fld2g5Sm4wMkNkRDFXNE9EX3VtSXVTMHNtak9KOXprTi1YMGlDNU9NRTlDaFJIM0VmeGQtMF92NkZfUzVhUnVIQzRNVkl5eFhZQjV4VmZOLXZuczd3WQ?oc=5","date":"2019-03-27","type":"patent","source":"JUVE Patent","summary":"UK Supreme Court finds ICOS patent invalid - JUVE Patent","headline":"UK Supreme Court finds ICOS patent invalid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNVmxNYVczRnJlelZMS0VzZlQ2TTQ5d3prVEN5OFI5akVNeC1sSnd5YW1hUWhWTFRCeHM3aHBmallZZWJ1UFdYUWRKNGJvTV8xMzZpUXhfaHhwUUo5cC1kZmNudDYxMkhjWm5IOTItZExHSURDVjVXdHlXSGtKTWtoSVFRcw?oc=5","date":"2018-04-19","type":"pipeline","source":"Northwestern University","summary":"Biotech Builder - Northwestern University","headline":"Biotech Builder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSFlQWmhPMG4xTHFzVDlpdGhBRGlVQjlXblVha1l4NkhkeGlfUC1EbzAzZnF5Q0RkQ0dEVWJpblc1LXJlNjNQa21UWjRjZjQ4blhUdWx5WmRxOHVNMDV4N0xIdnhDbE1KN0Fwak1kM1RQbEZVRU9HT1V1WVowdUc1UkloNkN5VkNBOExGN1F2SmpTS0xnSEduTnJaXzZpOGhOS3QzUXJVUUtBZw?oc=5","date":"2018-04-08","type":"pipeline","source":"Eli Lilly","summary":"Lilly Announces Acquisition of ICOS Corporation - Eli Lilly","headline":"Lilly Announces Acquisition of ICOS Corporation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVFFRZWplX0RNQm5Ta19WajR1YzNucFRBN2ZxdTJPWEdBZ19NY0xPaXBqNzdDd1A2a0xqVlowTjREUUVXQTN3MUhWbTZOd3ZJVkxnVWtTQzE1T3BTb3pLU0c1cW84OGV0aW9keEpUV29fMjhqRF9iV3hYNEs1LUtKbzQwYldNSXU2WUJkRkJOcmhqaW8xYXRUaFBXeU5GZ3pqZ0lDNEJRS0pjb2tIc0VhVnBXVXZyY2FL?oc=5","date":"2018-04-07","type":"pipeline","source":"Eli Lilly","summary":"Lilly Announces Completion of ICOS Corporation Acquisition - Eli Lilly","headline":"Lilly Announces Completion of ICOS Corporation Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPYzM4Vkw4QnhEeUNkR0lqS1Z4UDJJbk5FN292aW5kcWJXanRFNnNnM0dDREV5cGk1d0hSemZZRzRkUlZFTWNiRF9ENWQzTGY1cWZHRnRDdU5aWGhQQzZoT3RWckE1Nk1Rd1VORW5hOHZwUzE2al85U1h5dE1PT0JIOXU3UDUzN1ZJd1VwbTFaZi16enJMakE?oc=5","date":"2016-09-27","type":"patent","source":"European Pharmaceutical Review","summary":"Pharmaceutical patents: Clear the way but careful where you tread - European Pharmaceutical Review","headline":"Pharmaceutical patents: Clear the way but careful where you tread","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQSE02NGZLelZsOWVwNThFWlhjLXdtTnk3QktpUklYak1oRnQwblpfTkUtOU1BY2sweHpGdGVJRWRmMlNna1R3a0pObVlDbzBoclg4X3Z0VUE1MnJ6eXNnSXZCTkl4WlY5Y3pUUTVaYi03NkVJWEpwQWFnazdOMndpVV9JSQ?oc=5","date":"2010-11-15","type":"pipeline","source":"Pharmaceutical Technology","summary":"CMC Biologics Seattle Facility Expansion - Pharmaceutical Technology","headline":"CMC Biologics Seattle Facility Expansion","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}